Table 7.
Open surgery to correct femoral fractures in a tertiary-level hospital: skin colonization and etiological agents of the surgical site infection (July 2007–July 2009).
| Variable | Frequency | % |
|---|---|---|
| Etiological agent identified for SSI | ||
| Yes | 11 | 52 |
| No | 10 | 48 |
| Total | 21 | 100 |
| Etiological agent for SSI | ||
| Acinetobacter baumannii | 2 | 18 |
| Staphylococcus aureus | 2 | 18 |
| Enterobacter cloacae + Acinetobacter baumannii | 1 | 9 |
| Enterococcus sp. | 1 | 9 |
| Escherichia coli + Acinetobacter baumannii | 1 | 9 |
| Escherichia coli + Enterococcus sp. (ESBL-producing) | 1 | 9 |
| Proteus mirabilis | 1 | 9 |
| Proteus mirabilis + MRSA | 1 | 9 |
| Staphylococcus aureus + Enterococcus sp. | 1 | 9 |
| Total | 11 | 100 |
| Skin colonization? | ||
| Yes | 9 | 2 |
| No | 423 | 98 |
| Total | 432 | 100 |
| Skin microorganisms identified | ||
| Staphylococcus aureus | 5 | 55.0 |
| Staphylococcus aureus + Enterobacter sp. | 2 | 22.0 |
| Proteus mirabilis | 1 | 11.0 |
| Staphylococcus aureus + Streptococcus pyogenes | 1 | 11.0 |
| Total | 9 | 100.0 |
ESBL, extended-spectrum beta lactamase; MRSA, methicillin-resistant Staphylococcus aureus; SSI, surgical site infection.